製薬企業向け臨床試験供給・ロジスティクス市場：2025-2035
Clinical Trial Supply and Logistics Market for Pharma 2025-2035
説明
製薬企業の臨床試験供給・ロジスティクス市場 2025-203 (米国貿易関税の影響を含む）：本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
説明
製薬企業の臨床試験供給・ロジスティクス市場 2025-203(米国貿易関税の影響を含む）：本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとなろう。異業種への進出や、新たな地域での既存事業の拡大を目指す企業にとっても有用なレポートです。
サプライチェーンの混乱が市場の課題となる
グローバル・サプライチェーンは、パンデミック、地政学的紛争、原材料不足など、衝撃に対して非常に脆弱なままである。航空運賃の高騰、港湾の混雑、税関の遅延は、タイムラインを混乱させ、試験の完全性を危うくする。このような課題により、スポンサーは、多様な輸送オプション、戦略的に配置された地域デポ、強固な緊急時対応計画を提供できるロジスティクス・プロバイダーとの提携を迫られている。事業継続性を保証できないプロバイダーは、風評被害と商業的損失の両方のリスクを負うことになる。その結果、回復力と冗長性がパートナー選定の重要な差別化要因となり、治験薬供給・ロジスティクス（CTSL）市場の競争力学を再構築している。
米国の貿易関税が製薬企業の臨床試験供給とロジスティクスの世界市場に与える影響とは？
米国の貿易関税の賦課は、世界の臨床試験サプライ＆ロジスティクス（CTSL）市場全体に波及効果をもたらすと予想され、特に国境を越えた試験材料の移動に依存している企業は、運営コストの増大に直面することになる。輸入原薬、包装資材、特殊機器に対する関税の上昇は、特にジャスト・イン・タイム納品モデルに依存している臨床試験において、調達プロセスを遅らせ、予算を逼迫させる可能性がある。このように不確実性が高まる環境は、臨床のマイルストーンを遅らせ、新治療法の開発スケジュールを延長させるリスクがある。
関税は当面の財務的影響にとどまらず、長期的な戦略的決定にも影響を及ぼす可能性が高い。医薬品スポンサーや物流プロバイダーは、競争力を維持するために、サプライチェーンの地域化、地域物流ハブへの投資、無関税貿易ルートの確立を進めるかもしれない。しかし、経営資源が限られた中小企業は追加コストの吸収に苦戦し、グローバル・プレイヤーとニッチ・サービス・プロバイダーとの格差が拡大する可能性がある。このように、米国の関税はトライアル・ロジスティクスのコスト・ベースに圧力を加えるだけでなく、業界の競争環境を再定義する。
市場調査レポートを購入する前にすべき質問とは？
-
製薬企業向け臨床試験供給・ロジスティクス市場はどのように進化しているのか？
-
製薬企業向け臨床試験供給・ロジスティクス市場の促進要因と抑制要因は何か？
-
医薬品向け臨床試験サプライ・ロジスティクスの各サブマーケットセグメントは予測期間中にどのように成長し、2035年にはどれくらいの収益を占めるようになるのか？
-
2025年から2035年にかけて、製薬企業向け臨床試験供給・ロジスティクスサブマーケットごとの市場シェアはどのように推移するのか？
-
2025年から2035年にかけて、市場全体の主な牽引役となるのは何か？
-
製薬企業向け臨床試験供給・ロジスティクスの主要市場はマクロ経済の動きに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
-
2035年までに各国市場のシェアはどう変化し、2035年に市場をリードするのはどの地域か？
-
主要プレイヤーは誰で、予測期間中の見通しは？
-
これらの大手企業の製薬プロジェクトにおける臨床試験供給とロジスティクスとは？
-
2025年から2035年にかけて、業界はどのように発展していくのか？、現在および今後10年間に行われる医薬品プロジェクトの臨床試験供給・ロジスティクスにはどのような影響があるのか？
-
製薬企業向け臨床試験供給・ロジスティクス市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
-
製薬企業向け臨床試験供給・ロジスティクス市場はどこへ向かい、どのようにすれば市場の最前線に立てるのか？
-
新製品やサービスラインに対する最適な投資オプションは何か？
-
企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは
これが製薬企業向け臨床試験供給・ロジスティクス市場に現在、そして今後10年間でどのような影響を与えるかを明らかにする必要があります：
-
本レポートは272ページにわたり、115の表と129の図表で構成されています。
-
本レポートでは、業界における主要な有利分野をハイライトしているため、今すぐターゲットを絞ることができます。
-
世界、地域、国の売上と成長に関する詳細な分析が含まれています。
-
競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
2035年までの予測やその他の分析から、商業的な展望が見えてきた
-
2035年までの収益予測に加え、最新の実績、成長率、市場シェアも提供する。
-
ビジネスの展望や展開など、独自の分析が掲載されている。
-
定性的分析（市場ダイナミクス、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。
レポート対象セグメント
タイプ
-
CTSマニュファクチャリング
-
CTSロジスティクス＆物流
-
CT サプライチェーン・マネジメント
-
CTS梱包・保管
フェーズ
-
前臨床試験
-
フェーズI
-
フェーズII
-
フェーズIII
-
フェーズIV
-
ポストローンチ
I世界市場全体と各分野の売上予測に加え、5つの地域と26の主要国市場の売上予測も掲載しています：
北米
欧州
-
ドイツ
-
英国
-
フランス
-
Iタリー
-
スペイン
-
ロシア
-
オランダ
-
スイス
-
その他の欧州地域
アジア太平洋
-
日本
-
中国
-
Iンディア
-
オーストラリア
-
韓国
-
東南アジア
-
その他のアジア太平洋地域
ラテンアメリカ
-
ブラジル
-
メキシコ
-
アルゼンチン
-
コロンビア
-
その他のラテンアメリカ地域
MEA
本レポートでは、製薬企業の臨床試験供給・ロジスティクス市場の2025年から2035年にかけての主要企業のプロファイルも掲載しています。
主要企業と市場成長の可能性
-
Almac Group
-
Bilcare Limited
-
Biocair
-
Catalent, Inc.
-
COREX Logistics
-
Eurofins Scientific
-
FedEx
-
ICON plc
-
Intertek Group plc
-
Kerry Logistics Network Limited
-
Kuehne+Nagel
-
Marken (A UPS Company)
-
Mayne Pharma Group Limited
-
Movianto
-
NAF Pharma
-
Oximio
-
Parexel International Corporation
-
PCI Pharma Services (PCI)
-
Royal Cargo
-
Thermo Fisher Scientific Inc.
-
United Parcel Service, Inc.
-
Yourway
製薬企業向け臨床試験供給・ロジスティクス市場の2025年から2035年までの世界全体の売上高（金額ベース）は、2025年に160億米ドルを突破するとの試算を発表した。2035年まで売上は力強く成長すると予測している。
当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。
2025年から2035年までの製薬企業向け臨床試験供給・ロジスティクス市場」レポートはどのようにお役に立ちますか？
要約すると、270ページを超えるこのレポートは、以下のような知識を提供する：
-
製薬企業向け臨床供給・ロジスティクス市場の2025年から2035年までの収益予測、タイプ別・フェーズ別予測、世界レベル・地域レベルの各予測 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけます。
-
5つの地域と26の主要国市場の2035年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの製薬企業向け臨床試験供給・ロジスティクス市場の2025年から2035年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。
-
製薬企業向け臨床試験供給・ロジスティクス市場（2025年～2035年）に関わる主要企業25社の企業プロファイルを含む、既存企業および市場参入を目指す企業の展望。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を入手しましょう。
ページTOPに戻る
目次
1 レポート概要
1.1 調査の目的
1.2 医薬品向け治験薬供給・ロジスティクス市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通りです：
1.6 本レポートの対象者
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 治験の分散化／バーチャル化の動き
3.2.1.2 アジア太平洋諸国における臨床試験実施の可能性の増加
3.2.1.3 臨床試験件数の増加
3.2.1.4 臨床試験を追跡する統合ソリューション
3.2.2 市場抑制要因
3.2.2.1 臨床試験および医療コールドチェーン物流
3.2.2.2 輸送における人為的または自然的混乱
3.2.2.3 高い財務コスト
3.2.3 市場機会
3.2.3.1 AIと機械学習はより多くのデータとともに進化する
3.2.3.2 バーチャル治験とテクノロジーが患者や施設に受け入れられつつある
3.2.3.3 大企業が市場を牽引する
3.1 米国の関税：世界の製薬企業向け臨床試験供給・ロジスティクス市場への影響は？
3.1.1 概要
3.1.2 V字回復シナリオ
3.1.3 なぜV字回復なのか？
3.1.3.1 関税による影響
3.1.3.2 市場ダイナミクスと需要回復
3.1.3.3 政策と資金援助
3.1.3.4 回復のタイムフレーム
3.1.4 U字型回復シナリオ
3.1.4.1 なぜU字型回復なのか？
3.1.4.2 関税による影響
3.1.4.3 市場ダイナミクスと需要回復
3.1.4.4 政策と資金援助
3.1.4.5 回復のタイムフレーム
3.1.5 L字型回復シナリオ
3.1.5.1 なぜL字型回復なのか？
3.1.5.2 関税による影響
3.1.5.3 市場ダイナミクスと需要回復
3.1.5.4 政策と資金援助
3.1.5.5 回復のタイムフレーム
3.1.6 顧客が短期（2025?2030年）および長期（2025?2035年）計画に織り込むべき戦略的考慮事項とは？
3.1.7 米中貿易戦争が製薬市場の治験供給とロジスティクスに与える影響
3.1.8 最も影響を受ける国は、これらの政策変更によってどのようなプラス効果とマイナス効果を経験する可能性があるか？
3.2 ポーターのファイブフォース分析
3.2.1 サプライヤーの交渉力
3.2.2 バイヤーの交渉力
3.2.3 競争上のライバル関係
3.2.4 代替品の脅威
3.2.5 新規参入企業の脅威
3.3 PEST分析
4 製薬企業向け臨床供給・ロジスティクス市場分析：タイプ別
4.1 主要な調査結果
4.2 タイプ別セグメント 市場魅力度指数
4.3 製薬企業向け臨床試験供給・ロジスティクス市場タイプ別規模推定と予測
4.4 CTS製造
4.4.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
4.4.2 地域別市場シェア、2025年・2035年(%)
4.5 CTS物流・流通
4.5.1 地域別市場予測、2025～2035年（10億米ドル、AGR %)
4.5.2 2025年および2035年の地域別市場シェア(%)
4.6 CTサプライチェーン管理
4.6.1 2025年～2035年の地域別市場予測（10億米ドル、AGR %)
4.6.2 2025年および2035年の地域別市場シェア(%)
4.7 CTS包装・保管
4.7.1 地域別市場予測、2025～2035年（10億米ドル、AGR %)
4.7.2 地域別市場シェア、2025年・2035年(%)
5 製薬企業向け臨床試験供給・ロジスティクス市場分析：フェーズ別
5.1 主要な調査結果
5.2 フェーズセグメント 市場魅力度指数
5.3 製薬企業向け臨床試験供給・ロジスティクス市場フェーズ別規模推定と予測
5.4 前臨床
5.4.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.4.2 地域別市場シェア、2025年・2035年(%)
5.5 フェーズI
5.5.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.5.2 地域別市場シェア、2025年・2035年(%)
5.6 フェーズII
5.6.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.6.2 地域別市場シェア、2025年・2035年(%)
5.7 フェーズ III
5.7.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.7.2 地域別市場シェア、2025年・2035年(%)
5.8 第Ⅳ相
5.8.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.8.2 2025年および2035年の地域別市場シェア(%)
5.9 上市後
5.9.1 2025〜2035年の地域別市場予測（10億米ドル、AGR %)
5.9.2 2025年および2035年の地域別市場シェア(%)
6 製薬企業向け臨床試験供給・ロジスティクス市場分析：地域別
6.1 主要な調査結果
6.2 地域別市場規模の推定と予測
7 北米の製薬企業向け臨床試験供給・ロジスティクス市場分析
7.1 主要な調査結果
7.2 北米の製薬企業向け臨床試験供給・ロジスティクス市場魅力度指数
7.3 北米の製薬企業向け臨床試験供給・ロジスティクス市場の国別市場規模、2025年、2030年、2035年（10億米ドル
7.4 北米の製薬企業向け臨床試験供給・ロジスティクス国別市場規模推定と予測
7.5 北米の製薬企業向け臨床試験供給・ロジスティクス市場規模推定と予測：タイプ別
7.6 北米の製薬企業向け臨床試験供給・ロジスティクス市場規模推定と予測：フェーズ別
7.7 米国の製薬企業向け臨床試験供給・ロジスティクス市場分析
7.8 カナダの製薬企業向け臨床試験供給・ロジスティクス市場分析
8 欧州の製薬企業向け臨床試験供給・ロジスティクス市場分析
8.1 主要な調査結果
8.2 欧州の製薬企業向け臨床試験供給・ロジスティクス市場魅力度指数
8.3 欧州の製薬企業向け臨床試験供給・ロジスティクス国別市場規模、2025年、2030年、2035年 (10億米ドル)
8.4 欧州の製薬企業向け臨床試験供給・ロジスティクス国別市場規模推定と予測
8.5 欧州の製薬企業向け臨床試験供給・ロジスティクス市場規模推定と予測：タイプ別
8.6 欧州の製薬企業向け臨床試験供給・ロジスティクス市場規模推定と予測：フェーズ別
8.7 ドイツ製薬企業向け臨床試験供給・ロジスティクス市場分析
8.8 イギリス製薬企業向け臨床試験供給・ロジスティクス市場分析
8.9 フランス製薬企業向け臨床試験供給・ロジスティクス市場分析
8.10 イタリア 製薬企業向け臨床試験供給・ロジスティクス市場分析
8.11 スペインの製薬企業向け臨床試験供給・ロジスティクス市場分析
8.12 ロシア 製薬企業向け臨床試験供給・ロジスティクス市場の分析
8.13 オランダ 製薬企業向け臨床試験供給・ロジスティクス市場の分析
8.14 スイス製薬企業向け臨床試験供給・ロジスティクス市場の分析
8.15 その他の欧州の製薬企業向け臨床試験供給・ロジスティクス市場の分析
9 アジア太平洋地域の製薬企業向け臨床試験供給・ロジスティクス市場分析
9.1 主な調査結果
9.2 アジア太平洋地域の製薬企業向け臨床試験供給・ロジスティクス市場魅力度指数
9.3 アジア太平洋地域の製薬企業向け臨床試験供給・ロジスティクス国別市場規模、2025年、2030年、2035年（10億米ドル）
9.4 アジア太平洋地域の製薬企業向け臨床試験供給・ロジスティクス国別市場規模の推定と予測
9.5 アジア太平洋地域の製薬企業向け臨床試験供給・ロジスティクス市場規模の推定と予測：タイプ別
9.6 アジア太平洋地域の製薬企業向け臨床試験供給・ロジスティクス市場規模の推定と予測：フェーズ別
9.7 日本の製薬企業向け臨床試験供給・ロジスティクス市場分析
9.8 中国の製薬企業向け臨床試験供給・ロジスティクス市場分析
9.9 インドの製薬企業向け臨床試験供給・ロジスティクス市場分析
9.10 オーストラリアの製薬企業向け臨床試験供給・ロジスティクス市場分析
9.11 韓国の製薬企業向け臨床試験供給・ロジスティクス市場分析
9.12 東南アジアの製薬企業向け臨床試験供給・ロジスティクス市場分析
9.13 アジア太平洋地域その他における製薬企業向け臨床試験供給・ロジスティクス市場分析
10 ラテンアメリカの製薬企業向け臨床試験供給・ロジスティクス分析
10.1 主な調査結果
10.2 ラテンアメリカの製薬企業市場向け臨床試験供給・ロジスティクス魅力度指数
10.3 ラテンアメリカの製薬企業市場向け臨床試験供給・ロジスティクス国別市場規模、2025年、2030年、2035年（10億米ドル）
10.4 ラテンアメリカの製薬企業向け臨床試験供給・ロジスティクス国別市場規模推定と予測
10.5 ラテンアメリカの製薬企業向け臨床試験供給・ロジスティクス規模推定と予測：タイプ別
10.6 ラテンアメリカの製薬企業向け臨床試験供給・ロジスティクス規模推定と予測：フェーズ別
10.7 ブラジルの製薬企業向け臨床試験供給・ロジスティクス市場分析
10.8 メキシコの製薬企業向け臨床試験供給・ロジスティクス市場分析
10.9 アルゼンチンの製薬企業向け臨床試験供給・ロジスティクス市場分析
10.10 コロンビアの製薬企業向け臨床試験供給・ロジスティクス市場分析
10.11 その他のラテンアメリカ地域の製薬企業向け臨床試験供給・ロジスティクス市場分析
11 MEAの製薬企業向け臨床試験供給・ロジスティクス市場分析
11.1 主要な調査結果
11.2 MEAの製薬企業向け臨床試験供給・ロジスティクス市場魅力度指数
11.3 MEAの製薬企業向け臨床試験供給・ロジスティクス国別市場、2025年、2030年、2035年 (10億米ドル)
11.4 MEAの製薬企業向け臨床試験供給・ロジスティクス国別市場規模推定と予測
11.5 MEAの製薬企業向け臨床試験供給・ロジスティクス市場規模推定と予測：タイプ別
11.6 MEAの製薬企業向け臨床試験供給・ロジスティクス市場規模推定と予測：フェーズ別
11.7 GCCの製薬企業向け臨床試験供給・ロジスティクス市場分析
11.8 南アフリカ製薬企業向け臨床試験供給・ロジスティクス市場分析
11.9 MEA諸国以外の製薬企業向け臨床試験供給・ロジスティクス市場の分析
12 企業プロフィール
12.1 キャタレント社
12.1.1 会社概要
12.1.2 会社概要
12.1.3 財務分析
12.1.3.1 純収入、2020-2024年
12.1.3.2 地域市場シェア、2024年
12.1.4 サービス・ベンチマーク
12.1.5 戦略的展望
12.2 サーモフィッシャーサイエンティフィック
12.2.1 会社概要
12.2.2 会社概要
12.2.3 財務分析
12.2.3.1 純収入、2020-2024年
12.2.3.2 R＆D、2020-2024年
12.2.3.3 地域市場シェア、2024年
12.2.4 サービス・ベンチマーク
12.2.5 戦略的展望
12.3 アイコン・ピーエルシー
12.3.1 会社概要
12.3.2 会社概要
12.3.3 財務分析
12.3.3.1 売上高、2020-2024年
12.3.3.2 地域市場シェア、2023年
12.3.4 サービスベンチマーク
12.3.5 戦略的展望
12.4 ユーロフィンズ・サイエンティフィック
12.4.1 会社概要
12.4.2 会社概要
12.4.3 財務分析
12.4.3.1 純収入、2019-2022年
12.4.4 提供サービス
12.4.5 戦略的展望
12.5 フェデックス
12.5.1 会社概要
12.5.2 会社概要
12.5.3 財務分析
12.5.3.1 純収入、2020年～2024年
12.5.3.2 地域市場シェア、2024年
12.5.4 サービスベンチマーク
12.6 ユナイテッド・パーセル・サービス
12.6.1 会社概要
12.6.2 会社概要
12.6.3 財務分析
12.6.3.1 純収入、2020-2024年
12.6.4 サービスベンチマーク
12.7 Cencora, Inc.
12.7.1 会社概要
12.7.2 会社概要
12.7.3 財務分析
12.7.3.1 純収入、2020-2024年
12.7.4 サービスベンチマーク
12.8 DHLグループ
12.8.1 会社概要
12.8.2 会社概要
12.8.3 財務分析
12.8.3.1 純収入、2020-2024年
12.8.4 サービスベンチマーク
12.9 DKSHホールディング
12.9.1 会社概要
12.9.2 会社概要
12.9.3 サービス・ベンチマーク
12.10 ケリー・ロジスティクス・ネットワーク・リミテッド
12.10.1 会社概要
12.10.2 会社概要
12.10.3 財務分析
12.10.3.1 純収入、2019年～2023年
12.10.3.2 地域市場シェア、2024年
12.10.4 サービスベンチマーク
12.11 クエーン+ナーゲル
12.11.1 会社概要
12.11.2 会社概要
12.11.3 財務分析
12.11.3.1 純収入、2020-2024年
12.11.3.2 地域市場シェア、2024年
12.11.4 サービス・ベンチマーク
12.11.5 戦略的展望
12.12 ビルケア
12.12.1 会社概要
12.12.2 会社概要
12.12.3 サービス・ベンチマーク
12.13 メーン・ファーマ・グループ・リミテッド
12.13.1 会社概要
12.13.2 会社概要
12.13.3 財務分析
12.13.3.1 純収入、2020-2024年
12.13.3.2 地域市場シェア、2024年
12.13.4 サービスベンチマーク
12.14 インターテックグループ
12.14.1 会社概要
12.14.2 会社概要
12.14.3 財務分析
12.14.3.1 純収入、2020-2024年
12.14.4 サービス・ベンチマーク
12.15 アルマックグループ
12.15.1 会社概要
12.15.2 会社概要
12.15.3 サービス・ベンチマーク
12.15.4 戦略的展望
12.16 パレクセル・インターナショナル・コーポレーション
12.16.1 会社概要
12.16.2 会社概要
12.16.3 サービス・ベンチマーク
12.16.4 戦略的展望
12.17 バイオケア
12.17.1 会社概要
12.17.2 会社概要
12.17.3 サービス・ベンチマーク
12.17.4 戦略的展望
12.18 マーケン（UPS傘下）
12.18.1 会社概要
12.18.2 会社概要
12.18.3 サービス・ベンチマーク
12.19 PCIファーマサービス（PCI）
12.19.1 会社概要
12.19.2 会社概要
12.19.3 サービス・ベンチマーク
12.19.4 戦略的展望
12.20 モビアント
12.20.1 会社概要
12.20.2 会社概要
12.20.3 サービス・ベンチマーク
12.21 ユアウェイ
12.21.1 会社概要
12.21.2 会社概要
12.21.3 サービス・ベンチマーク
12.22 コーレックス・ロジスティクス
12.22.1 会社概要
12.22.2 会社概要
12.22.3 サービスベンチマーク
12.23 オキシミオ
12.23.1 会社概要
12.23.2 会社概要
12.23.3 サービス・ベンチマーク
12.24 ロイヤル・カーゴ
12.24.1 会社概要
12.24.2 会社概要
12.24.3 サービス・ベンチマーク
12.25 NAFファーマ
12.25.1 会社概要
12.25.2 会社概要
12.25.3 サービス・ベンチマーク
13 結論と提言
13.1 ビジョンゲインからの結びの言葉
13.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
List of Tables
Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): “V” Shaped Recovery
Table 3 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): “U” Shaped Recovery
Table 4 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): “L” Shaped Recovery
Table 5 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 6 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 17 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 28 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 31 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 32 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 33 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 34 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 35 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 36 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 37 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 38 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 39 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 40 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 41 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 44 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 45 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 48 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 49 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 51 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 52 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 53 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 54 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 60 Catalent, Inc.: Service Benchmarking
Table 61 Catalent, Inc.: Strategic Outlook
Table 62 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 64 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 65 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 ICON plc: Service Benchmarking
Table 67 ICON plc: Strategic Outlook
Table 68 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Eurofins Scientific: Services Offered
Table 70 Eurofins Scientific: Strategic Outlook
Table 71 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 FedEx: Service Benchmarking
Table 73 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 United Parcel Service, Inc.: Service Benchmarking
Table 75 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Cencora, Inc.: Service Benchmarking
Table 77 DHL Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 DHL Group: Service Benchmarking
Table 79 DKSH Holding Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 DKSH Holding Ltd.: Service Benchmarking
Table 81 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 KERRY LOGISTICS NETWORK LIMITED: Service Benchmarking
Table 83 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Kuehne+Nagel: Service Benchmarking
Table 85 Kuehne+Nagel: Strategic Outlook
Table 86 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Bilcare Limited: Service Benchmarking
Table 88 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Mayne Pharma Group Limited: Service Benchmarking
Table 90 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Intertek Group plc: Service Benchmarking
Table 92 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Almac Group: Service Benchmarking
Table 94 Almac Group: Strategic Outlook
Table 95 Parexel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Parexel International Corporation: Service Benchmarking
Table 97 Parexel International Corporation: Strategic Outlook
Table 98 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Biocair: Service Benchmarking
Table 100 Biocair: Strategic Outlook
Table 101 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Marken (A UPS Company): Service Benchmarking
Table 103 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 PCI Pharma Services (PCI): Service Benchmarking
Table 105 PCI Pharma Services (PCI): Strategic Outlook
Table 106 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Movianto: Service Benchmarking
Table 108 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Yourway: Service Benchmarking
Table 110 COREX Logistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 COREX Logistics: Service Benchmarking
Table 112 Oximio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Oximio: Service Benchmarking
Table 114 Royal Cargo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Royal Cargo: Service Benchmarking
Table 116 NAF Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 NAF Pharma: Service Benchmarking
List of Figures
Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
Figure 5 Clinical Trials Supply and Logistics Market: Market Dynamics
Figure 6 Clinical Trials Initiated by Phase, 2023
Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 10 Short Term & Long Term Planning
Figure 11 Impact of U.S. and China Trade War
Figure 12 Most Impacted Countries
Figure 13 Clinical Trial Supply and Logistics for Pharma Market: Porter’s Five Forces Analysis
Figure 14 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
Figure 15 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 16 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 17 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025, 2030, 2035 (%)
Figure 18 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 CTS Manufacturing Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 20 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 21 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 22 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 23 CT Supply Chain Management Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 24 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 CTS Packaging & Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 26 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 27 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 28 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025, 2030, 2035 (%)
Figure 29 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 30 Preclinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 32 Phase I Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 34 Phase II Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 35 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 36 Phase III Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 37 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 38 Phase IV Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 39 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 40 Post Launch Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 41 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 42 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 43 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 49 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 50 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 51 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 52 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 53 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 59 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 60 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 61 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 62 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 63 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 64 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 65 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 66 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 67 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 68 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 69 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 70 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 74 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 75 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 76 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 77 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 78 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 79 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 80 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 81 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 82 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 83 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 84 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 85 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 89 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 90 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 91 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 92 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 93 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 94 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 95 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 96 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 97 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 100 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 104 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 105 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 106 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 107 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 108 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 109 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 110 Catalent, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 111 Catalent, Inc.: Regional Market Shares, 2024
Figure 112 Thermo Fisher Scientific Inc: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 113 Thermo Fisher Scientific Inc: R&D, 2020-2024 (US$ Million, AGR %)
Figure 114 Thermo Fisher Scientific Inc: Regional Market Shares, 2024
Figure 115 ICON plc: Revenue, 2020-2024 (US$ Million, AGR %)
Figure 116 ICON plc: Regional Market Shares, 2023
Figure 117 Eurofins Scientific: Net Revenue, 2019-2022 (US$ Million, AGR %)
Figure 118 FedEx: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 119 FedEx: Regional Market Shares, 2024
Figure 120 United Parcel Service, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 121 Cencora, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 122 DHL Group: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 123 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 124 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2024
Figure 125 Kuehne+Nagel: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 126 Kuehne+Nagel: Regional Market Shares, 2024
Figure 127 Mayne Pharma Group Limited: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 128 Mayne Pharma Group Limited: Regional Market Shares, 2024
Figure 129 Intertek Group plc: Net Revenue, 2020-2024 (US$ Million, AGR %)
ページTOPに戻る
Summary
Description
The Clinical Trial Supply and Logistics Market for Pharma 2025-203 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Supply Chain Disruptions Pose Market Challenges
Global supply chains remain highly vulnerable to shocks, whether from pandemics, geopolitical conflicts, or raw material shortages. Rising air freight costs, port congestion, and customs delays disrupt timelines and jeopardise trial integrity. These challenges are pushing sponsors to partner with logistics providers that can offer diversified transport options, strategically located regional depots, and robust contingency planning. Providers unable to guarantee business continuity risk both reputational damage and commercial losses. As a result, resilience and redundancy have become critical differentiators in partner selection, reshaping the competitive dynamics of the clinical trial supply and logistics (CTSL) market.
What would be the Impact of US Trade Tariffs on the Global Clinical Trial Supply and Logistics for Pharma Market?
The imposition of U.S. trade tariffs is expected to create ripple effects across the global clinical trial supply and logistics (CTSL) market, particularly as companies dependent on cross-border movement of trial materials face mounting operational costs. Increased tariffs on imported APIs, packaging materials, and specialised equipment can slow procurement processes and tighten budgets, especially for trials that rely on just-in-time delivery models. This environment of heightened uncertainty risks delaying clinical milestones and extending development timelines for new therapies.
Beyond the immediate financial impact, tariffs are likely to influence long-term strategic decisions. Pharmaceutical sponsors and logistics providers may increasingly localise supply chains, invest in regional distribution hubs, or establish tariff-free trade routes to safeguard competitiveness. However, smaller firms with limited resources could struggle to absorb additional costs, widening the gap between global players and niche service providers. In this way, U.S. tariffs not only add pressure to the cost base of trial logistics but also redefine the competitive landscape of the industry.
What Questions Should You Ask before Buying a Market Research Report?
-
How is the clinical trial supply and logistics for pharma market evolving?
-
What is driving and restraining the clinical trial supply and logistics for pharma market?
-
How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
-
How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2025 to 2035?
-
What will be the main driver for the overall market from 2025 to 2035?
-
Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
-
How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
-
Who are the leading players and what are their prospects over the forecast period?
-
What are the clinical trial supply and logistics for pharma projects for these leading companies?
-
How will the industry evolve during the period between 2025 and 2035? What are the implications of
clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?
-
Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
-
Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
-
What are the best investment options for new product and service lines?
-
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:
-
Our 272-page report provides 115 tables and 129 charts/graphs exclusively to you.
-
The report highlights key lucrative areas in the industry so you can target them – NOW.
-
It contains in-depth analysis of global, regional and national sales and growth.
-
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2035 and other analyses reveal commercial prospects
-
In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
-
You will find original analyses, with business outlooks and developments.
-
Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Type
-
CTS Manufacturing
-
CTS Logistics & Distribution
-
CT Supply Chain Management
-
CTS Packaging & Storage
Phase
-
Preclinical
-
Phase I
-
Phase II
-
Phase III
-
Phase IV
-
Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:
North America
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Netherlands
-
Switzerland
-
Rest of Europe
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
South-East Asia
-
Rest of Asia Pacific
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Colombia
-
Rest of Latin America
MEA
-
GCC
-
South Africa
-
Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
-
Almac Group
-
Bilcare Limited
-
Biocair
-
Catalent, Inc.
-
COREX Logistics
-
Eurofins Scientific
-
FedEx
-
ICON plc
-
Intertek Group plc
-
Kerry Logistics Network Limited
-
Kuehne+Nagel
-
Marken (A UPS Company)
-
Mayne Pharma Group Limited
-
Movianto
-
NAF Pharma
-
Oximio
-
Parexel International Corporation
-
PCI Pharma Services (PCI)
-
Royal Cargo
-
Thermo Fisher Scientific Inc.
-
United Parcel Service, Inc.
-
Yourway
Overall world revenue for Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 in terms of value the market will surpass US$16.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 report help you?
In summary, our 270+ page report provides you with the following knowledge:
-
Revenue forecasts to 2035 for Clinical Trial Supply and Logistics Market for Pharma 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
-
Revenue forecasts to 2035 for five regional and 26 key national markets – See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
-
Prospects for established firms and those seeking to enter the market – including company profiles for 25 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
ページTOPに戻る
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Move Towards Decentralized/Virtual Trials
3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
3.2.1.3 Growing Clinical Trials Volume
3.2.1.4 Integrated Solution to Track Clinical Trials
3.2.2 Market Restraining Factors
3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
3.2.2.2 Man-made or Natural Disruption in Transportation
3.2.2.3 High Financial Cost
3.2.3 Market Opportunities
3.2.3.1 AI and Machine Learning are Evolving with More Data
3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
3.2.3.3 Big Companies are driving the Market
3.1 U.S. Tariffs: What’s the Impact on Global Clinical Trial Supply and Logistics for Pharma Market?
3.1.1 Overview
3.1.2 V-Shaped Recovery Scenario
3.1.3 Why V-Shaped Recovery?
3.1.3.1 Impact from Tariffs
3.1.3.2 Market Dynamics and Demand Recovery
3.1.3.3 Policy and Funding Support
3.1.3.4 Timeframe for Recovery
3.1.4 U-Shaped Recovery Scenario
3.1.4.1 Why U-Shaped Recovery?
3.1.4.2 Impact from Tariffs
3.1.4.3 Market Dynamics and Demand Recovery
3.1.4.4 Policy and Funding Support
3.1.4.5 Timeframe for Recovery
3.1.5 L Shaped Recovery Scenario
3.1.5.1 Why L-Shaped Recovery?
3.1.5.2 Impact from Tariffs
3.1.5.3 Market Dynamics and Demand Recovery
3.1.5.4 Policy and Funding Support
3.1.5.5 Timeframe for Recovery
3.1.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025–2030) and Long-term (2025–2035) Planning?
3.1.7 Impact of U.S. and China Trade War on Clinical Trial Supply and Logistics for Pharma Market
3.1.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.2 Porter’s Five Forces Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Competitive Rivalry
3.2.4 Threat of Substitutes
3.2.5 Threat of New Entrants
3.3 PEST Analysis
4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
4.4 CTS Manufacturing
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 CTS Logistics & Distribution
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)
4.6 CT Supply Chain Management
4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2025 & 2035 (%)
4.7 CTS Packaging & Storage
4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2025 & 2035 (%)
5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
5.4 Preclinical
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Phase I
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Phase II
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Phase III
5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Phase IV
5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2025 & 2035 (%)
5.9 Post Launch
5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2025 & 2035 (%)
6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
7.1 Key Findings
7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis
8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
8.1 Key Findings
8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
8.13 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
8.14 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
8.15 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
9.1 Key Findings
9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
10.1 Key Findings
10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
10.9 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
10.10 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
10.11 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
11.1 Key Findings
11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
12 Company Profiles
12.1 Catalent, Inc.
12.1.1 Company Snapshot
12.1.2 Company Overview
12.1.3 Financial Analysis
12.1.3.1 Net Revenue, 2020-2024
12.1.3.2 Regional Market Shares, 2024
12.1.4 Service Benchmarking
12.1.5 Strategic Outlook
12.2 Thermo Fisher Scientific Inc.
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2020-2024
12.2.3.2 R&D, 2020-2024
12.2.3.3 Regional Market Shares, 2024
12.2.4 Service Benchmarking
12.2.5 Strategic Outlook
12.3 ICON plc
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Revenue, 2020-2024
12.3.3.2 Regional Market Shares, 2023
12.3.4 Service Benchmarking
12.3.5 Strategic Outlook
12.4 Eurofins Scientific
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2019-2022
12.4.4 Services Offered
12.4.5 Strategic Outlook
12.5 FedEx
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2020-2024
12.5.3.2 Regional Market Shares, 2024
12.5.4 Service Benchmarking
12.6 United Parcel Service, Inc.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2020-2024
12.6.4 Service Benchmarking
12.7 Cencora, Inc.
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2020-2024
12.7.4 Service Benchmarking
12.8 DHL Group
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2020-2024
12.8.4 Service Benchmarking
12.9 DKSH Holding Ltd.
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Service Benchmarking
12.10 KERRY LOGISTICS NETWORK LIMITED
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2019-2023
12.10.3.2 Regional Market Shares, 2024
12.10.4 Service Benchmarking
12.11 Kuehne+Nagel
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2020-2024
12.11.3.2 Regional Market Shares, 2024
12.11.4 Service Benchmarking
12.11.5 Strategic Outlook
12.12 Bilcare Limited
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Service Benchmarking
12.13 Mayne Pharma Group Limited
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2020-2024
12.13.3.2 Regional Market Shares, 2024
12.13.4 Service Benchmarking
12.14 Intertek Group plc
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Financial Analysis
12.14.3.1 Net Revenue, 2020-2024
12.14.4 Service Benchmarking
12.15 Almac Group
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Service Benchmarking
12.15.4 Strategic Outlook
12.16 Parexel International Corporation
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Service Benchmarking
12.16.4 Strategic Outlook
12.17 Biocair
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Service Benchmarking
12.17.4 Strategic Outlook
12.18 Marken (A UPS Company)
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Service Benchmarking
12.19 PCI Pharma Services (PCI)
12.19.1 Company Snapshot
12.19.2 Company Overview
12.19.3 Service Benchmarking
12.19.4 Strategic Outlook
12.20 Movianto
12.20.1 Company Snapshot
12.20.2 Company Overview
12.20.3 Service Benchmarking
12.21 Yourway
12.21.1 Company Snapshot
12.21.2 Company Overview
12.21.3 Service Benchmarking
12.22 COREX Logistics
12.22.1 Company Snapshot
12.22.2 Company Overview
12.22.3 Service Benchmarking
12.23 Oximio
12.23.1 Company Snapshot
12.23.2 Company Overview
12.23.3 Service Benchmarking
12.24 Royal Cargo
12.24.1 Company Snapshot
12.24.2 Company Overview
12.24.3 Service Benchmarking
12.25 NAF Pharma
12.25.1 Company Snapshot
12.25.2 Company Overview
12.25.3 Service Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): “V” Shaped Recovery
Table 3 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): “U” Shaped Recovery
Table 4 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): “L” Shaped Recovery
Table 5 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 6 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 17 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 28 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 31 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 32 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 33 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 34 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 35 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 36 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 37 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 38 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 39 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 40 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 41 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 44 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 45 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 48 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 49 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 51 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 52 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 53 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 54 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 60 Catalent, Inc.: Service Benchmarking
Table 61 Catalent, Inc.: Strategic Outlook
Table 62 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 64 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 65 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 ICON plc: Service Benchmarking
Table 67 ICON plc: Strategic Outlook
Table 68 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Eurofins Scientific: Services Offered
Table 70 Eurofins Scientific: Strategic Outlook
Table 71 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 FedEx: Service Benchmarking
Table 73 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 United Parcel Service, Inc.: Service Benchmarking
Table 75 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Cencora, Inc.: Service Benchmarking
Table 77 DHL Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 DHL Group: Service Benchmarking
Table 79 DKSH Holding Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 DKSH Holding Ltd.: Service Benchmarking
Table 81 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 KERRY LOGISTICS NETWORK LIMITED: Service Benchmarking
Table 83 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Kuehne+Nagel: Service Benchmarking
Table 85 Kuehne+Nagel: Strategic Outlook
Table 86 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Bilcare Limited: Service Benchmarking
Table 88 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Mayne Pharma Group Limited: Service Benchmarking
Table 90 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Intertek Group plc: Service Benchmarking
Table 92 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Almac Group: Service Benchmarking
Table 94 Almac Group: Strategic Outlook
Table 95 Parexel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Parexel International Corporation: Service Benchmarking
Table 97 Parexel International Corporation: Strategic Outlook
Table 98 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Biocair: Service Benchmarking
Table 100 Biocair: Strategic Outlook
Table 101 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Marken (A UPS Company): Service Benchmarking
Table 103 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 PCI Pharma Services (PCI): Service Benchmarking
Table 105 PCI Pharma Services (PCI): Strategic Outlook
Table 106 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Movianto: Service Benchmarking
Table 108 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Yourway: Service Benchmarking
Table 110 COREX Logistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 COREX Logistics: Service Benchmarking
Table 112 Oximio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Oximio: Service Benchmarking
Table 114 Royal Cargo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Royal Cargo: Service Benchmarking
Table 116 NAF Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 NAF Pharma: Service Benchmarking
List of Figures
Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
Figure 5 Clinical Trials Supply and Logistics Market: Market Dynamics
Figure 6 Clinical Trials Initiated by Phase, 2023
Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 10 Short Term & Long Term Planning
Figure 11 Impact of U.S. and China Trade War
Figure 12 Most Impacted Countries
Figure 13 Clinical Trial Supply and Logistics for Pharma Market: Porter’s Five Forces Analysis
Figure 14 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
Figure 15 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 16 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 17 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025, 2030, 2035 (%)
Figure 18 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 CTS Manufacturing Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 20 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 21 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 22 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 23 CT Supply Chain Management Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 24 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 CTS Packaging & Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 26 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 27 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 28 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025, 2030, 2035 (%)
Figure 29 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 30 Preclinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 32 Phase I Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 34 Phase II Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 35 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 36 Phase III Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 37 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 38 Phase IV Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 39 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 40 Post Launch Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 41 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 42 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 43 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 49 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 50 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 51 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 52 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 53 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 59 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 60 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 61 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 62 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 63 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 64 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 65 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 66 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 67 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 68 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 69 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 70 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 74 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 75 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 76 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 77 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 78 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 79 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 80 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 81 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 82 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 83 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 84 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 85 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 89 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 90 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 91 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 92 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 93 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 94 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 95 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 96 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 97 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 100 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 104 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 105 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 106 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 107 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 108 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 109 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 110 Catalent, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 111 Catalent, Inc.: Regional Market Shares, 2024
Figure 112 Thermo Fisher Scientific Inc: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 113 Thermo Fisher Scientific Inc: R&D, 2020-2024 (US$ Million, AGR %)
Figure 114 Thermo Fisher Scientific Inc: Regional Market Shares, 2024
Figure 115 ICON plc: Revenue, 2020-2024 (US$ Million, AGR %)
Figure 116 ICON plc: Regional Market Shares, 2023
Figure 117 Eurofins Scientific: Net Revenue, 2019-2022 (US$ Million, AGR %)
Figure 118 FedEx: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 119 FedEx: Regional Market Shares, 2024
Figure 120 United Parcel Service, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 121 Cencora, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 122 DHL Group: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 123 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 124 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2024
Figure 125 Kuehne+Nagel: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 126 Kuehne+Nagel: Regional Market Shares, 2024
Figure 127 Mayne Pharma Group Limited: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 128 Mayne Pharma Group Limited: Regional Market Shares, 2024
Figure 129 Intertek Group plc: Net Revenue, 2020-2024 (US$ Million, AGR %)
ページTOPに戻る
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
